Healthcare & Life Sciences
Revolo Biotherapeutics, formerly Immune Regulation
Revolo Biotherapeutics, formerly Immune Regulation is a Healthcare & Life Sciences startup, most recent round Series B, 2 tracked investors.
series-b
series-b
Stage
2
Investors
About Revolo Biotherapeutics, formerly Immune Regulation
Revolo Biotherapeutics, formerly Immune Regulation is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Explore Revolo Biotherapeutics, formerly Immune Regulation's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.